Literature DB >> 10847630

Induced nitric oxide inhibits IL-6-induced stat3 activation and type II acute phase mRNA expression.

R T Villavicencio1, S Liu, M R Kibbe, D L Williams, R W Ganster, K F Dyer, D J Tweardy, T R Billiar, B R Pitt.   

Abstract

Inducible nitric oxide synthase (iNOS) can be coexpressed with acute phase reactants in hepatocytes; however, it is unknown if NO can regulate the acute phase response. We tested the hypothesis that iNOS-derived nitric oxide (NO) attenuates the acute phase response by inhibiting IL-6-enhanced Stat3 DNA-binding activity and type II acute phase mRNA expression. iNOS was overexpressed in cultured rat hepatocytes via transduction with a replication defective adenovirus containing cDNA for human iNOS (AdiNOS), and Stat3 DNA-binding activity was determined by electrophoretic mobility shift assay (EMSA). EMSAs demonstrated that AdiNOS inhibits IL-6-induced Stat3 activation and that this inhibition is reversible in the presence of the NOS inhibitor N(G)-monomethyl-L-arginine (L-NMA). The induction of beta-fibrinogen mRNA by IL-6, a Stat3 dependent process, is attenuated in AdiNOS-transduced cells and partially reversed by L-NMA. Thus, iNOS overexpression suppresses IL-6-induced Stat3 activation and type II acute phase mRNA expression in cultured hepatocytes. This suppression may represent a mechanism by which NO down-regulates the acute phase response.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10847630     DOI: 10.1097/00024382-200006000-00004

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  6 in total

1.  Regulation of type 17 helper T-cell function by nitric oxide during inflammation.

Authors:  Wanda Niedbala; Jose C Alves-Filho; Sandra Y Fukada; Silvio Manfredo Vieira; Akio Mitani; Fabiane Sonego; Ananda Mirchandani; Daniele C Nascimento; Fernando Q Cunha; Foo Y Liew
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

2.  Interleukin-1beta-induced promatrilysin expression is mediated by NFkappaB-regulated synthesis of interleukin-6 in the prostate carcinoma cell line, LNCaP.

Authors:  M S Maliner-Stratton; R D Klein; T S Udayakumar; R B Nagle; G T Bowden
Journal:  Neoplasia       Date:  2001 Nov-Dec       Impact factor: 5.715

3.  Attenuation of biopterin synthesis prevents Escherichia coli K1 invasion of brain endothelial cells and the development of meningitis in newborn mice.

Authors:  Muthusamy V Shanmuganathan; Subramanian Krishnan; Xiaowei Fu; Nemani V Prasadarao
Journal:  J Infect Dis       Date:  2012-10-24       Impact factor: 5.226

4.  Nitroalkenes suppress lipopolysaccharide-induced signal transducer and activator of transcription signaling in macrophages: a critical role of mitogen-activated protein kinase phosphatase 1.

Authors:  Tomonaga Ichikawa; Jifeng Zhang; Kai Chen; Yusen Liu; Francisco J Schopfer; Paul R S Baker; Bruce A Freeman; Yuqing E Chen; Taixing Cui
Journal:  Endocrinology       Date:  2008-05-08       Impact factor: 4.736

5.  IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.

Authors:  Ahmed-Amine Zergoun; Abderezak Zebboudj; Sarah Leila Sellam; Nora Kariche; Djamel Djennaoui; Samir Ouraghi; Esma Kerboua; Zine-Charaf Amir-Tidadini; Dalia Chilla; Fatima Asselah; Chafia Touil-Boukoffa; Taha Merghoub; Mehdi Bourouba
Journal:  Tumour Biol       Date:  2015-10-09

6.  Hypertension and increased endothelial mechanical stretch promote monocyte differentiation and activation: roles of STAT3, interleukin 6 and hydrogen peroxide.

Authors:  Roxana Loperena; Justin P Van Beusecum; Hana A Itani; Noah Engel; Fanny Laroumanie; Liang Xiao; Fernando Elijovich; Cheryl L Laffer; Juan S Gnecco; Jonathan Noonan; Pasquale Maffia; Barbara Jasiewicz-Honkisz; Marta Czesnikiewicz-Guzik; Tomasz Mikolajczyk; Tomasz Sliwa; Sergey Dikalov; Cornelia M Weyand; Tomasz J Guzik; David G Harrison
Journal:  Cardiovasc Res       Date:  2018-09-01       Impact factor: 10.787

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.